Increased skeletal muscle 11βHSD1 mRNA is associated with lower muscle strength in ageing

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Kilgour, Alixe H M ^a   Gallagher, Iain J ^a   MacLullich, Alasdair M J ^a   Andrew, Ruth ^b   Gray, Calum D ^c   Hyde, Philippa ^a   Wackerhage, Henning ^d   Husi, Holger ^a   Ross, James A ^a   Starr, John M ^a   Chapman, Karen E ^b   Fearon, Kenneth C H ^a   Walker, Brian R ^b   Greig, Carolyn A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADULT; AGE FACTORS; AGED; AGING; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; IMMUNOASSAY; MALE; MUSCLE STRENGTH; MUSCLE WEAKNESS; MUSCLE, SKELETAL; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, GLUCOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; YOUNG ADULT;

EID: 84894212486     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084057     Document Type: Article

References (39)

1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, et al. (2010) Sarcopenia: European consensus on definition and diagnosis. Age and Ageing 39: 412-423.
2. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, et al. (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12: 249-256.
3. Muscaritoli M, Anker SD, Argiles J, Aversa Z, Bauer JM, et al. (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clinical Nutrition 29: 154-159.
4. Janssen I, Heymsfield SB, Wang ZM, Ross R (2000) Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. Journal of Applied Physiology 89: 81-88. (Pubitemid 30482566)
5. Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, et al. (2006) The loss of skeletal muscle strength, mass, and quality in older adults: The health, aging and body composition study. Journals of Gerontology Series a-Biological Sciences and Medical Sciences 61: 1059-1064.
6. Frontera WR, Hughes VA, Fielding RA, Fiatarone MA, Evans WJ, et al. (2000) Aging of skeletal muscle: a 12-yr longitudinal study. Journal of Applied Physiology 88: 1321-1326. (Pubitemid 30217433)
7. Skelton DA, Greig CA, Davies JM, Young A (1994) Strength, power and related functional ability of healthy people aged 65-89 years. Age and Ageing 23: 371-377. (Pubitemid 24292161)
8. Starr JM, Deary IJ (2011) Socio-economic position predicts grip strength and its decline between 79 and 87 years: the Lothian Birth Cohort 1921. Age Ageing 40: 749-752.
9. Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, et al. (2003) Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 95: 1851-1860. (Pubitemid 37310367)
10. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, et al. (1998) Epidemiology of sarcopenia among the elderly in New Mexico. American Journal of Epidemiology 147: 755-763. (Pubitemid 28183275)
11. Rantanen T (2003) Muscle strength, disability and mortality. Scand J Med Sci Sports 13: 3-8.
12. Welle S (2002) Cellular and molecular basis of age-related sarcopenia. Canadian Journal of Applied Physiology-Revue Canadienne De Physiologie Appliquee 27: 19-41.
13. Sayer A, Robinson S, Patel H, Shavlakadze T, Cooper C, et al. (2013) New horizons in the pathogenesis, diagnosis and management of sarcopenia. Age and Ageing 42: 145-150.
14. Schakman O, Gilson H, Thissen J (2008) Mechanisms of glucocorticoid induced myopathy. Journal of Endocrinology 197: 1-10.
15. Shah O, Kimball S, Jefferson L (2000) Acute attenuation of translation initiation and protein synthesis by glucocorticoids in skeletal muscle. Am J Physiol Endocrinol Metab 278: E76-82. (Pubitemid 30101922)
16. Jang C, Obeyesekere VR, Dilley RJ, Alford FP, Inder WJ (2006) 11 beta hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle. Clinical Endocrinology 65: 800-805. (Pubitemid 44772361)
17. Whorwood CB, Donovan SJ, Wood PJ, Phillips DI (2001) Regulation of glucocorticoid receptor alpha and beta isoforms and type I 11beta-hydroxysteroid dehydrogenase expression in human skeletal muscle cells: a key role in the pathogenesis of insulin resistance? Journal of Clinical Endocrinology & Metabolism 86: 2296-2308. (Pubitemid 32472955)
18. Hughes KA, Manolopoulos KN, Iqbal J, Cruden NL, Stimson RH, et al. (2012) Recycling between cortisol and cortisone in human splanchnic, subcutaneous adipose, and skeletal muscle tissues in vivo. Diabetes 61: 1357-1364.
19. Tiganescu A, Tahrani A, Morgan S, Otranto M, Desmoulière A, et al. (2013) 11b-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects. J Clin Invest 123: 3051-3060.
20. Hughes KA, Webster SP, Walker BR (2008) 11-Beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors in type 2 diabetes mellitus and obesity. Expert Opin Investig Drugs 17: 481-496. (Pubitemid 351578167)
21. Waters DL, Qualls CR, Dorin RI, Veldhuis JD, Baumgartner RN (2008) Altered growth hormone, cortisol, and leptin secretion in healthy elderly persons with sarcopenia and mixed body composition phenotypes. Journals of Gerontology Series a-Biological Sciences and Medical Sciences 63: 536-541.
22. Peeters GMEE, van Schoor NM, van Rossum EFC, Visser M, Lips P (2008) The relationship between cortisol, muscle mass and muscle strength in older persons and the role of genetic variations in the glucocorticoid receptor. Clinical Endocrinology 69: 673-682.
23. Izquierdo M, Hakkinen K, Anton A, Garrues M, Ibanez J, et al. (2001) Maximal strength and power, endurance performance, and serum hormones in middle-aged and elderly men. Med Sci Sports Exerc 33: 1577-1587. (Pubitemid 32831449)
24. Gardner MP, Lightman SL, Gallacher J, Hardy R, Kuh D, et al. (2011) Diurnal cortisol patterns are associated with physical performance in the Caerphilly Prospective Study. Int J Epidemiol 40: 1693-1702.
25. Best R, Walker BR (1997) Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11 beta-hydroxysteroid dehydrogenase in vivo. Clinical Endocrinology 47: 231-236. (Pubitemid 27359904)
26. Wake DJ, Rask E, Livingstone DEW, Soderberg S, Olsson T, et al. (2003) Local and systemic impact of transcriptional up-regulation of 11 beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. Journal of Clinical Endocrinology & Metabolism 88: 3983-3988. (Pubitemid 37034555)
27. Greig CA, Young A, Skelton DA, Pippet E, Butler FMM, et al. (1994) Exercise studies with elderly volunteers. Age and Ageing 23: 185-189. (Pubitemid 24158285)
28. Edwards RH, Hyde S (1977) Methods of measuring muscle strength and fatigue. Physiotherapy 63: 51-55. (Pubitemid 8031144)
29. Gray C, MacGillivray TJ, Eeley C, Stephens NA, Beggs I, et al. (2011) Magnetic resonance imaging with k-means clustering objectively measures whole muscle volume compartments in sarcopenia/cancer cachexia. Clinical Nutrition 30: 106-111.
30. Bergström J (1975) Percutaneous Needle Biopsy of Skeletal Muscle in Physiological and Clinical Research. Scandinavian Journal of Clinical & Laboratory Investigation 35: 609-616.
31. Stephens NA, Gallagher IJ, Rooyackers O, Skipworth RJ, Tan BH, et al. (2010) Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia. Genome medicine 2: 1.
32. Young A, Stokes M, Crowe M (1985) The size and strength of the quadriceps muscles of old and young men. Clinical Physiology 5: 145-154. (Pubitemid 15104694)
33. Hook P, Sriramoju V, Larsson L (2001) Effects of aging on actin sliding speed on myosin from single skeletal muscle cells of mice, rats, and humans. American Journal of Physiology-Cell Physiology 280: C782-C788.
34. Haus JM, Carrithers JA, Trappe SW, Trappe TA (2007) Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle. Journal of Applied Physiology 103: 2068-2076. (Pubitemid 350232392)
35. Mitsui T, Azuma H, Nagasawa M, Iuchi T, Akaike M, et al. (2002) Chronic corticosteroid administration causes mitochondrial dysfunction in skeletal muscle. Journal of Neurology 249: 1004-1009. (Pubitemid 35002220)
36. van Rossum EFC, Voorhoeve PG, te Velde SJ, Koper JW, Delemarre-van de Waal HA, et al. (2004) The ER22/23EK Polymorphism in the Glucocorticoid Receptor Gene Is Associated with a Beneficial Body Composition and Muscle Strength in Young Adults. Journal of Clinical Endocrinology & Metabolism 89: 4004-4009. (Pubitemid 39071507)
37. Aniansson A, Sperling L, Rundgren A, Lehnberg E (1983) Muscle function in 75-year-old men and women - a longitudinal-study. Scandinavian Journal of Rehabilitation Medicine: 92-102. (Pubitemid 14135053)
38. Aniansson A, Hedberg M, Henning GB, Grimby G (1986) Muscle morphology, enzymatic-activity, and muscle strength in elderly men - a follow-up-study. Muscle & Nerve 9: 585-591. (Pubitemid 16012696)
39. Aniansson A, Grimby G, Hedberg M (1992) Compensatory muscle-fiber hypertrophy in elderly men. Journal of Applied Physiology 73: 812-816.